Nantahala Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001472322
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 142 positions · Total reported value $2.00B · Top-10 concentration 34.1% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 34.3% · 25 new · 19 cut · 13 exited
Active Share (vs S&P 500): 99.8% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.1% · Prev Value $2.49B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.3% · vs SPY -4.5% · Latest Value $2.18B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2025 13F filing, Nantahala Capital Management, LLC disclosed 142 equity positions with a combined reported value of $2.00B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 34.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were EW ($153.45M), TEVA ($78.03M), TBBK ($72.36M). By sector, the heaviest allocations are Health Care 62.5%, Consumer Discretionary 17.4%. Versus the prior quarter, allocation shifted toward Health Care (+13.1pp), Consumer Discretionary (+5.1pp) and away from Other (-20.7pp).
Versus the prior quarter, Nantahala Capital Management, LLC opened 25 new positions, trimmed 19 and fully exited 13, a turnover rate of 34.3% of positions. The portfolio's overlap with the prior quarter was 78% of names.
The largest new positions opened in Q4 2025 were GOGO ($31.65M), CHYM ($15.10M), USNA ($11.49M).
Of the 13 positions fully exited versus the prior quarter, the largest were KRYS ($35.31M), PVLA ($15.68M), HOOD ($14.32M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
Fully Exited (vs previous quarter)
- KRYS KRYSTAL BIOTECH INC · prev qtr: $35.31M · history
- PVLA PALVELLA THERAPEUTICS INC NE · prev qtr: $15.68M
- HOOD ROBINHOOD MKTS INC · prev qtr: $14.32M
- DYN DYNE THERAPEUTICS INC · prev qtr: $8.89M
- RDVT RED VIOLET INC · prev qtr: $8.59M
- CYTK CYTOKINETICS INC · prev qtr: $8.24M
- DCTH DELCATH SYS INC · prev qtr: $7.16M
- VTGN VISTAGEN THERAPEUTICS INC · prev qtr: $7.02M
Insider Transactions (Form 4)
Latest Nantahala Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Nantahala Capital Management, LLC is an SEC-registered 13F filer based in New Canaan, CT, United States. As of Q2 2026 it reported 141 US equity positions with a combined value of $2.49B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW CANAAN, CT, United States
- SEC registration: 801-72481 (status: Approved), registered 2011-06-24
- Regulatory AUM (Form ADV): $3.11B as of 2026-09-14
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 3 private funds, of which 3 hedge funds
- Website: nantahalapartners.com
Portfolio Structure
- 141 positions · $2.49B reported value (Q2 2026)
- Top 10 holdings = 43.8% of reported value
- Largest position: IWM (ISHARES TR) at 24.1%
- Average position size: $17.65M
Sector Tilt
- Health Care 51.0%
- Consumer Discretionary 14.7%
- Financials 2.5%
- (classified holdings cover 71% of value)
Quarterly Activity
- Q2 2026: 24 new, 23 added, 38 reduced, 20 exited
- 56 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.80M | $153.45M | 7.66% | Hold | |
| 2 |
|
2.50M | $78.03M | 3.90% | Hold | |
| 3 |
|
1.07M | $72.36M | 3.61% | Add | |
| 4 |
|
987.69K | $71.98M | 3.59% | Reduce | |
| 5 |
|
5.00M | $62.25M | 3.11% | Hold | |
| 6 |
|
68.39M | $53.62M | 2.68% | Hold | |
| 7 |
|
400.00K | $48.77M | 2.44% | Reduce | |
| 8 |
|
4.29M | $48.56M | 2.42% | Reduce | |
| 9 |
|
1.07M | $48.11M | 2.40% | Add | |
| 10 |
|
6.05M | $44.99M | 2.25% | Add | |
| 11 |
|
7.34M | $44.29M | 2.21% | Reduce | |
| 12 |
|
5.82M | $38.71M | 1.93% | Add | |
| 13 |
|
2.19M | $37.44M | 1.87% | Add | |
| 14 |
|
5.93M | $36.55M | 1.82% | Add | |
| 15 |
|
6.79M | $31.65M | 1.58% | New | |
| 16 |
|
3.57M | $31.65M | 1.58% | Add | |
| 17 |
|
40.00K | $30.87M | 1.54% | Hold | |
| 18 |
|
2.45M | $30.84M | 1.54% | Reduce | |
| 19 |
|
6.85M | $30.50M | 1.52% | Hold | |
| 20 |
|
117.16K | $28.84M | 1.44% | Reduce | |
| 21 |
|
754.15K | $25.54M | 1.27% | Add | |
| 22 |
|
10.85M | $23.86M | 1.19% | Reduce | |
| 23 |
|
502.00K | $23.24M | 1.16% | Add | |
| 24 |
|
1.24M | $22.43M | 1.12% | Hold | |
| 25 |
|
153.24K | $20.66M | 1.03% | Reduce | |
| 26 |
|
1.18M | $19.89M | 0.99% | Hold | |
| 27 |
|
224.96K | $19.64M | 0.98% | Reduce | |
| 28 |
|
5.48M | $19.33M | 0.96% | Add | |
| 29 |
|
5.06M | $19.04M | 0.95% | Add | |
| 30 |
|
130.30K | $18.57M | 0.93% | Hold | |
| 31 |
|
1.22M | $18.36M | 0.92% | Add | |
| 32 |
|
477.09K | $17.63M | 0.88% | Reduce | |
| 33 |
|
1.15M | $17.10M | 0.85% | Hold | |
| 34 |
|
699.30K | $16.73M | 0.83% | Reduce | |
| 35 |
|
865.99K | $16.41M | 0.82% | Add | |
| 36 |
|
2.42M | $16.36M | 0.82% | Add | |
| 37 |
|
644.69K | $16.28M | 0.81% | Hold | |
| 38 |
|
1.77M | $15.88M | 0.79% | Reduce | |
| 39 |
|
100.00K | $15.62M | 0.78% | Hold | |
| 40 |
|
375.00K | $15.45M | 0.77% | Hold | |
| 41 |
|
600.00K | $15.10M | 0.75% | New | |
| 42 |
|
675.00K | $15.03M | 0.75% | Hold | |
| 43 |
|
2.07M | $14.45M | 0.72% | Add | |
| 44 |
|
1.07M | $14.00M | 0.70% | Hold | |
| 45 |
|
1.04M | $13.99M | 0.70% | Add | |
| 46 |
|
3.97M | $13.91M | 0.69% | Add | |
| 47 |
|
494.97K | $13.44M | 0.67% | Reduce | |
| 48 |
|
600.00K | $13.40M | 0.67% | Hold | |
| 49 |
|
3.38M | $13.26M | 0.66% | Hold | |
| 50 |
|
7.06M | $12.99M | 0.65% | Hold | |
FAQ
What did Nantahala Capital Management, LLC buy in 2025-Q4?
In its 2025-Q4 13F filing, Nantahala Capital Management, LLC reported 142 equity positions worth $2.00B in aggregate; its largest disclosed positions were EW ($153.45M), TEVA ($78.03M), TBBK ($72.36M).
How large is Nantahala Capital Management, LLC's portfolio?
Nantahala Capital Management, LLC reported $2.00B of long equity holdings across 142 positions as of 2025-Q4. Top-10 holdings account for 34.1% of reported value.
What is Nantahala Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.